Artwork

Content provided by Sky News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sky News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Could Ozempic save you from a heart attack?

17:56
 
Share
 

Manage episode 418243925 series 1146612
Content provided by Sky News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sky News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Anti-obesity jabs like Ozempic could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug.
Researchers found after three years of treatment participants had a 20% lower risk of obesity and its associated health impacts, which currently cost the NHS over £6bn per year.
On the Sky News Daily, Niall Paterson speaks to Sky’s science and medical correspondent Thomas Moore about the implications of reducing heart disease cases for the NHS, and senior lecturer in physiology at Anglia Ruskin University Dr Simon Cork explains how the wonder-drug actually works.
Producer: Emma Rae Woodhouse
Podcast Promotions Producer: David Chipakupaku
Editor: Philly Beaumont
  continue reading

1432 episodes

Artwork
iconShare
 
Manage episode 418243925 series 1146612
Content provided by Sky News. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Sky News or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Anti-obesity jabs like Ozempic could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount of weight they lose while on the drug.
Researchers found after three years of treatment participants had a 20% lower risk of obesity and its associated health impacts, which currently cost the NHS over £6bn per year.
On the Sky News Daily, Niall Paterson speaks to Sky’s science and medical correspondent Thomas Moore about the implications of reducing heart disease cases for the NHS, and senior lecturer in physiology at Anglia Ruskin University Dr Simon Cork explains how the wonder-drug actually works.
Producer: Emma Rae Woodhouse
Podcast Promotions Producer: David Chipakupaku
Editor: Philly Beaumont
  continue reading

1432 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide